BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.44
-0.62 (-3.43%)
At close: Apr 28, 2026, 4:00 PM EDT
17.16
-0.28 (-1.58%)
After-hours: Apr 28, 2026, 5:53 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $774.30 million as of April 28, 2026. Its market cap has increased by 529.69% in one year.
Market Cap
774.30M
Enterprise Value
494.28M
1-Year Change
529.69%
Ranking
Category
Stock Price
$17.44
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $774.30M, an increase of 25.90%. That is a compound annual growth rate of 15.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 801.82M | 69.03% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alvotech | 1.10B |
| Evotec SE | 1.07B |
| Collegium Pharmaceutical | 1.06B |
| Pacira BioSciences | 1.03B |
| Cronos Group | 1.00B |
| Amphastar Pharmaceuticals | 971.75M |
| Tilray Brands | 782.50M |
| Ironwood Pharmaceuticals | 684.84M |